Upload
others
View
12
Download
0
Embed Size (px)
Citation preview
GlaxoSmithKlinePositions on U.S. Legislation
GlaxoSmithKline took positions on (supported or opposed) 6 bills in the U.S. Congress from Jan. 1, 2007 to May 6, 2012.
1 Bill: H.R. 3261 (112th Congress) Sponsor: Rep. Lamar Smith (R, TX-21)Stop Online Piracy Act
Summary: To promote prosperity, creativity, entrepreneurship, and innovation by combating the theft of U.S.property, and for other purposes.
Status: The bill has been introduced.
Position: SupportedDate of position: Dec. 14, 2011Source: Letters and Testimonies; To the Members of the United States Congress (link)Retrieved: Jan. 26, 2012Source attached as: Appendix A -- page 3
2 Bill: H.R. 1249 (112th Congress) Sponsor: Rep. Lamar Smith (R, TX-21)Leahy-Smith America Invents Act
Summary: To amend title 35, United States Code, to provide for patent reform. Status: The bill has become law.
Position: SupportedDate of position: June 21, 2011Source: Press Releases; The Coalition for 21st Century Patent Reform reaffirms its support for moving H.R.
1249. (link)Retrieved: May 1, 2012Source attached as: Appendix B -- page 14
3 Bill: S. 606 (112th Congress) Sponsor: Sen. Robert Casey (D, PA)Creating Hope Act of 2011
Summary: A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the priority review voucherincentive program relating to tropical and rare pediatric diseases.
Status: The bill has been introduced.
Position: SupportedDate of position: March 17, 2011Source: Robert P. Casey, Jr. United States Senator for Pennsylvania; Casey Introduces Bipartisan Bill to Help
Develop Treatments for Rare Diseases (link)Retrieved: July 15, 2011Source attached as: Appendix C -- page 16
Page 1
4 Bill: S. 23 (112th Congress) Sponsor: Sen. Patrick Leahy (D, VT)America Invents Act
Summary: A bill to amend title 35, United States Code, to provide for patent reform. Status: The bill was voted on in the Senate on March 8, 2011.
Position: SupportedDate of position: March 8, 2011Source: Press Releases; Senate panel backs patent overhaul bill (link)Retrieved: June 22, 2011Source attached as: Appendix D -- page 19
5 Bill: H.R. 3080 (112th Congress) Sponsor: Rep. Eric Cantor (R, VA-7)United States-Korea Free Trade Agreement Implementation Act
Summary: To implement the United States-Korea Free Trade Agreement. Status: The bill has become law.
Position: SupportedDate of position: Jan. 5, 2011Source: US Chamber of Commerce; Letter to Members of the 112th Congress (link)Retrieved: May 2, 2012
6 Bill: S. 515 (111th Congress) Sponsor: Sen. Patrick Leahy (D, VT)Patent Reform Act of 2009
Summary: A bill to amend title 35, United States Code, to provide for patent reform. Status: The bill has passed through committee and has been put on a legislative calendar.
Position: SupportedDate of position: April 2, 2009Source: Press Releases; Coalition Supports Patent Reform Legislation Adopted in Senate Judiciary Committee
(link)Retrieved: May 2, 2012Source attached as: Appendix E -- page 20
Data source:
Support and opposition information is based on public documents found by MapLight, including congressional testimony, news reports,and company statements. This report of positions taken on legislation should not be considered comprehensive, as there may beadditional legislation GlaxoSmithKline supports or opposes that MapLight research did not reveal. Report generated May 7, 2012.Copyright © 2012 MapLight. All rights reserved.
Page 2
APPENDIX A GlaxoSmithKline - Positions on Legislation - By MapLight - May 7, 2012 Page 3
December 14, 2011
TO THE MEMBERS OF THE UNITED STATES CONGRESS:
The undersigned businesses, trade associations, and professional and labor organizations,representing a broad cross-section of the American economy, write in support of rogue siteslegislation. We commend both the House and the Senate for their attention to this importantissue.
We urge Congress to enact legislation that targets those who abuse the Internet ecosystem andreap illegal profits by stealing the intellectual property (IP) of America’s innovative and creativeindustries. These rogue sites—websites dedicated to counterfeiting and piracy—put Americanjobs, consumers, and innovation at risk.
Using the veil of sophisticated and well-designed websites, many of these online IP thieves poseas legitimate businesses, luring consumers to purchase fraudulent products. Some rogue siteseven sell dangerous and defective goods that jeopardize the health and safety of Americanconsumers who are deceived into purchasing consumer goods that are poorly constructed or evencontaminated with dangerous toxins. Consumers also unwittingly put themselves at risk ofidentity theft and malicious computer viruses by visiting these sites.
IP-intensive industries are a cornerstone of the U.S. economy, employing more than 19 millionpeople and accounting for 60 percent of exports. Rampant online counterfeiting and piracypresents a clear and present threat to American jobs and innovation. A study examinedapproximately 100 rogue sites and found that these sites attracted more than 53 billion visits peryear, which averages out to approximately nine visits for every man, woman, and child on Earth.Global sales of counterfeit goods via the Internet from illegitimate retailers reached $135 billionin 2010. The theft of American IP is the theft of American jobs.
The United States cannot and should not tolerate this criminal activity. Not only are jobs andconsumers at risk, but rogue sites contribute absolutely no value to the U.S. marketplace. Theoperators of rogue sites break laws, do not pay taxes, and skirt accountability. In light of theseconcerns, we urge you to enact carefully balanced rogue sites legislation this year. We commendthe House and the Senate for their attention to this important issue and look forward to workingwith you in support of that goal.
Sincerely,
1-800 Contacts, Inc.
1-800-PetMeds
1K Studios
2b1 Inc
3M Company
ABRO Industries, Inc.
APPENDIX A GlaxoSmithKline - Positions on Legislation - By MapLight - May 7, 2012 Page 4
Acushnet Company
adidas America
Advanced Medical Technology Association (AdvaMed)
Allen Russell Photography
Alliance of Automobile Manufacturers
Alliance of Visual Artists (AVA)
Altria Client Services
American Apparel and Footwear Association
American Association of Independent Music (A2IM)
American Board of Internal Medicine
American Federation of Musicians
American Gramaphone LLC
American Made Alliance
American Mental Health Counselors Association
American Photographic Artists
American Society of Composers, Authors and Publishers (ASCAP)
American Society of Media Photographers
American Society of Picture Professionals
American Watch Association
Anatoly Pronin Photography
Andrea Rugg Photography
Anti-Counterfeiting and Piracy Initiative (ACAPI)
Applied DNA Sciences
Art Holeman Photography
Association of American Publishers (AAP)
Association of Equipment Manufacturers
Association of Independent Music Publishers (AIMP)
Association of Test Publishers
AstraZeneca plc
Australian Medical Council
Autodesk, Inc.
Automotive Aftermarket Industry Association
Baker & Taylor Ent.
Bay State Psychological Associates
Beachbody, LLC
Beam Global Spirits & Wine
Benchmade Knife Company
Bill Parker Studios Inc.
Blue Sky Studios, Inc.
Bose Corporation
APPENDIX A GlaxoSmithKline - Positions on Legislation - By MapLight - May 7, 2012 Page 5
Braasch Biotech LLC
Brian Stevenson Photography
Brigid Collins Family Support Center
Broadcast Music, Inc. (BMI)
Build Media, Inc.
Burberry
Burning House Records
Burton Snowboards
C. F. Martin & Co., Inc.
Callaway Golf Company
Canada Goose
Cascade Designs Incorporated
Caterpillar Inc.
Caveon, LLC
CBS Corporation
Cengage Learning
Center for Credentialing & Education
Center Stage Photography
CFA Institute
Chanel USA
Christopher Semmes Photography
Chrysler Group LLC
Church Music Publishers Association
Cimarron Group
CMH Images
Coach
Coalition Against Counterfeiting and Piracy (CACP)
Columbia Sportswear Company
Comcast Corporation
Commercial Photo Design
Commercial Photographers International
Comprehensive Adult Student Assessment System
Consumer Healthcare Products Association
Copyright Alliance
Copyright Clearance Center (CCC)
Coty Inc.
Council of Fashion Designers of America
Country Music Association
Creative America Campaign Inc.
Creative Microsystems Corporation
APPENDIX A GlaxoSmithKline - Positions on Legislation - By MapLight - May 7, 2012 Page 6
CropLife America
Cross-Entertainment LLC
CSA Group
CVS Caremark
D'Addario & Company, Inc.
Dan Sherwood Photography
Danita Delimont Stock Photography
Dayco Products, LLC
Deluxe Entertainment Services Group
Dennyfoto
Derek DiLuzio Photography
DeVaul Photography
Diffraction LTD
Direct Selling Association (DSA)
Directional Insight
DIRECTV
Distefano Enterprises Inc.
Dolby Laboratories, Inc.
Dolce & Gabbana USA, INC.
Dollar General Corporation
Don Grall Photography
Doriguzzi Photographic Artistry
Dunford Architectural Photography
Eagle Rock Entertainment
Economic Strategy Group
Ed McDonald Photography
Educational & Industrial Testing Service
Electronic Arts, Inc.
Electronic Components Industry Association (ECIA)
Electronic Retailing Association
Eli Lilly and Company
Englebert Photography
Entertainment Software Association (ESA)
ERAI, Inc.
Eric Meola Studio Inc
ESPN Inc.
Evidence Photographers International Council
Ex Officio
Exxel Outdoors
FAME Publishing Co., LLC.
APPENDIX A GlaxoSmithKline - Positions on Legislation - By MapLight - May 7, 2012 Page 7
FAME Recording Studios
Far Bank Enterprises
Fashion Business Incorporated
Federation of State Boards of Physical Therapy
Fender Musical Instrument Company
FilmL.A., Inc.
Five By Five Inc.
Footwear Distributors & Retailers of America (FDRA)
Ford Motor Company
Fortune Brands, Inc.
Fred J. Lord Photography
GAR Associates
Gelderland Productions, L.L.C.
Gemvision Corporation
Gibson Guitar Corp.
GlaxoSmithKline
Gospel Music Association
Governors America Corp.
Graduate Management Admission Council
Graphic Artists Guild
Greeting Card Association (GCA)
Greg Nikas Photography
Gucci America, Inc.
Guru Denim
H.S. Marketing & Design, Inc.
Harley-Davidson Motor Company
HarperCollins Publishers
Harry Fox Agency
Hastings Entertainment, Inc.
ICM Distributing Company, Inc.
IDS Publishing
IEC Electronics corp.
Images Plus
Imaging Supplies Coalition (ISC)
IMAX Corporation
Independent Distributors of Electronics Association (IDEA)
INgrooves
Innate-gear
InterContinental Hotels Group (IHG)
International AntiCounterfeiting Coalition (IACC)
APPENDIX A GlaxoSmithKline - Positions on Legislation - By MapLight - May 7, 2012 Page 8
International Trademark Association (INTA)
IPC-Association Connecting Electronics Industries
IPCybercrime.com LLC
Ira Montgomery Photography
J.S. Grove Photography
James Drug Inc.
Jaynes Gallery
JCPage Photography
Jean Poland Photography
Jeff Stevensen Photography
John Fulton Photography
John Wiley & Sons, Inc.
Johnson & Johnson
Juicy Couture, Inc
Julien McRoberts Photography
K&R Photographics
kate spade
Kekepana International Services
Kenneth Garrett, photographer for National Geographic
Killing Jar Productions LLC
Lacoste USA
Laurent Bouzereau, producer for Nedland Media, Inc.
Leatherman Tool Group, Inc.
Lexmark International, Inc.
Lieberman Research Worldwide
Light Perspectives
Linda Olsen Photography
Little Dog Records
Liz Claiborne, Inc
L'Oréal USA
Lucky Brand Jeans
LVMH Moët Hennessy Louis Vuitton
Macmillan
Major League Baseball
Major League Soccer
Marcia Andberg Associates LLC
Mark Niederman Photography
Marmot
Marona Photography
McLain Photography Inc
APPENDIX A GlaxoSmithKline - Positions on Legislation - By MapLight - May 7, 2012 Page 9
Merck & Co., Inc.
Messy Face Designs, Inc.
Michael Stern Photography
MicroRam Electronics, Inc.
Minor League Baseball
Minter Works of Art
Mira Images
Mob Scene Creative Productions
Monster Cable Products, Inc.
Moose’s Photos
Morningstar Films LLC
Motion Picture Association of America, Inc. (MPAA)
MotionMasters
Motor & Equipment Manufacturers Association
MPA - The Association of Magazine Media
Mr. Theodor Feibel (sole proprietor)
Music Managers Forum-U.S.
Nashville Songwriters Association International
Natalie Neckyfarow Actor/Dancer/Singer
National Association of Broadcasters
National Association of Manufacturers
National Association of Music Merchants
National Association of Recording Merchandisers (NARM)
National Association of Theatre Owners (NATO)
National Basketball Association (NBA)
National Board for Certified Counselors
National Board for Certified Counselors Foundation
National Confectioners Association
National Electrical Manufacturers Association (NEMA)
National Football League (NFL)
National Music Publishers' Association (NMPA)
National Retail Federation (NRF)
NBCUniversal
Nervous Tattoo Inc., dba Ed Hardy
New Balance Athletic Shoe, Inc.
New Era Cap Co Inc
New Levels Ent. Co. LLC
News Corporation
Next Decade Entertainment, Inc.
NHL Enterprises, L.P.
APPENDIX A GlaxoSmithKline - Positions on Legislation - By MapLight - May 7, 2012 Page 10
Nicholas Petrucci, Artist, LLC
Nike, Inc.
Nintendo of America Inc.
Nissle Fine Art Photography
North Dakota Pharmacists Association
North Dakota Pharmacy Service Corporation
Oakley, Inc.
One Voice Recordings
OpSec Security, Inc.
Outdoor Industry Association
Outdoor Power Equipment Institute (OPEI)
Outdoor Research, Inc
Pacific Component Xchange, Inc.
Party Killer Films LLC
Pearson Clinical Assessment
Peavey Electronics Corporation
Perry Ellis International
Personal Care Products Council
Peter C. Brandt, Architectural and Fine Art Photography
Peter Hawkins Photography, Inc.
Petzl America
Pfizer Inc.
PGA of America
Philip Morris International
Photojournalist Dave Bartruff
Picture Archive Council of America (PACA)
Pigfactory Music
PING
PNW Images
Premier League
Production Music Association (PMA)
Professional Photographers of America
Quality Float Works, Inc.
Raging Waters Music
Ralph Lauren Corporation
Ramsay Corporation
Rebel Photo
Recording Industry Association of America (RIAA)
Red Wing Shoe Company
Red4 Music/Doogs Rock Inc
APPENDIX A GlaxoSmithKline - Positions on Legislation - By MapLight - May 7, 2012 Page 11
Reebok International Ltd.
Reed Elsevier Inc.
Renie Design
Retail Industry Leaders Association (RILA)
Reverb Productions
Revlon
Richard Flutie Photography
Rite Aid
Robin Davis Photography, Inc.
Rodger Scott Craig, a member of Liverpool Express, The Merseybeats, Fortune, Harlan Cage,
101 South, and Mtunz Media
Roger Smith Photography Services
Rolex Watch USA Inc.
Romance Writers of America (RWA)
Romin, Inc.
Rosenthal Consulting LLC
Rosetta Stone Inc.
Saddle Creek
Sage Studios LLC
Sam D'Amico Photography
Schneider Electric
Sean McGinty Photography
Secret Sea Visions (Photography)
SESAC, Inc.
SG Industries, Inc.
Shure Incorporated
SIGMA Assessment Systems
Six Degrees Records
Small Business & Entrepreneurship Council
SMC Entertainment
SMT Corp.
SoBe Entertainment
Soccer United Marketing
Society of Sport & Event Photographers
Software & Information Industry Association (SIIA)
Sony Electronics Inc.
Sony Music Entertainment
Sony Pictures Entertainment
Soul Appeal Records and Music
SoundExchange
APPENDIX A GlaxoSmithKline - Positions on Legislation - By MapLight - May 7, 2012 Page 12
Southern Gothic LLC
Specialty Equipment Market Association (SEMA)
SPI (The Plastics Industry Trade Association)
Sporting Goods Manufacturers Association
Sports Rights Owners Coalition
Spring Fever Productions LLC
Spyder Active Sports, Inc
Stenbakken Photography
Stephen Dantzig Photography
Stock Artists Alliance
Stuart Weitzman Holdings, LLC
Student Photographic Society
Studio 404
SunRise Solar Inc.
Taylor Glenn Photographs
Taylor Guitars
Taylor Made Golf Company, Inc.
Technicolor
Tednologies, Inc.
The Cambridge Don
The Collegiate Licensing Company/IMG College
The Donath Group, Inc.
The Dow Chemical Company
The DVD Cafe'
The EMI Group
The Estee Lauder Companies
The McGraw-Hill Companies
The Music People! Inc.
The National Collegiate Athletic Association (NCAA)
The Nielsen Co.
The Recording Academy (National Academy of Recording Arts and Sciences)
The Timberland Company
The Walt Disney Company
Tiffany & Co.
Tighe Creative Solutions, Inc.
Time Warner Inc.
Tony Bullard Photography
Toshiba America Business Solutions, Inc.
TRA Global
Trailer Park
APPENDIX A GlaxoSmithKline - Positions on Legislation - By MapLight - May 7, 2012 Page 13
Tricoast Worldwide
Trio Productions, Inc. / Songscape Music,
Twist & Shout, Inc.
U.S. Chamber of Commerce
Ultimate Fighting Championship
Under Armour
Underwriters Laboratories Inc.
United States Tennis Association
Universal Music Group
Uniweld Products Inc.
VF Corporation
Viacom
Vibram USA, Inc
Victorinox Swiss Army, Inc.
Virtual Chip Exchange USA, Inc.
Voltage Pictures, LLC
W.R. Case & Sons Cutlery Co.
Walcott Studio, LLC
Wal-Mart
Warner Music Group
Wendy Kaveney Photography
Western Psychological Services
Westmorland Images, LLC
Wild & Associates, Inc.
Wild Eye Photos LLC
William Sutton Photography
Willis Music
WindLegends Ink LLC
Winestem Company
Winslow Research Institute
Wolfe Video
Wolverine World Wide, Inc.
Woolrich, Inc.
World Wrestling Entertainment, Inc.
Xerox Corporation
Zippo Manufacturing Company
Zumba Fitness, LLC
APPENDIX B GlaxoSmithKline - Positions on Legislation - By MapLight - May 7, 2012 Page 14
APPENDIX B GlaxoSmithKline - Positions on Legislation - By MapLight - May 7, 2012 Page 15
APPENDIX C GlaxoSmithKline - Positions on Legislation - By MapLight - May 7, 2012 Page 16
Printer-friendly
Robert P. Casey Jr.
United States Senator for Pennsylvania
Casey Introduces Bipartisan Bill to Help Develop Treatments for Rare DiseasesThursday, March 17, 2011
WASHINGTON, DC— U.S. Senator Bob Casey (D-PA) today introduced the Creating Hope Act of
2011, a bipartisan bill that would encourage the development of new treatments for rare and
neglected diseases that disproportionately affect children. The bill, which also has broad support
among the medical community, patient advocates and biopharmaceutical companies, would
strengthen a cost-neutral FDA program giving biopharmaceutical companies an incentive to develop
treatments for rare diseases that are often less profitable than treatments for more common medical
conditions.
“Millions of Americans are affected by rare diseases and neglected conditions for which there is
currently no hope because there is no treatment,” said Senator Casey. “The Creating Hope Act
brings light where there is now only darkness by providing an incentive, at no cost to taxpayers, to
develop treatments for these illnesses. The broad support for this legislation speaks to the need to
solve this problem.”
The Creating Hope Act is cosponsored by Senators Scott Brown (R-MA), Sherrod Brown (D-OH), Al
Franken (D-MN) and Johnny Isakson (R-GA).
Rare diseases, such as pediatric cancers, and neglected tropical diseases, such as malaria, affect
significant numbers of Americans and people around the globe. More than 20 million Americans
have a rare disease, according to the National Organization for Rare Disorders. An estimated one
billion people worldwide suffer from a neglected tropical disease according to the World Health
Organization, and children are most frequently and profoundly affected by these conditions.
“I applaud Senator Casey’s leadership in introducing the Creating Hope Act,” said Nancy Goodman,
Executive Director of Kids v. Cancer. “I want to ensure that one day, children like my son, Jacob,
who are diagnosed with brain cancer and other serious and rare diseases, will have drugs available
for safe and effective treatments.”
Peter C. Adamson, M.D., Chair of the Children’s Oncology Group at the Children’s Hospital of
Philadelphia, said: “I commend Senator Casey and his colleagues for introducing the Creating Hope
Act of 2011. As a pediatric oncologist who leads the Children’s Oncology Group, a nationwide team
of physicians, scientists, nurses and others dedicated to treating children with cancer, I know that
improving the outcome for children with cancer will require development of new, more effective
Robert P. Casey Jr. | United States Senator for Pennsylvania: Newsroom - ... http://casey.senate.gov/newsroom/press/release/?id=a8deb1ac-6ffd-424b...
1 of 3 7/15/2011 11:37 AM
APPENDIX C GlaxoSmithKline - Positions on Legislation - By MapLight - May 7, 2012 Page 17
anti-cancer drugs. With cancer remaining the leading cause of disease related death in children in
the United States, the Creating Hope Act of 2011 will provide a critically important new way to help
engage scientists in the biopharmaceutical industry to help develop better medicines for the children
we care for.”
“Long a pioneer in pediatric medical research, Children’s Hospital of Pittsburgh of UPMC is
committed to seeking new and innovative therapies for the cure of childhood diseases and disability
– no matter how rare,’’ said David H. Perlmutter, MD, Physician-in-Chief and Scientific Director.
“Creating incentives for companies to invest in new treatments will help ensure our continued
advancement in providing the most exceptional medical care for the most vulnerable children.”
“Of the nearly one in 10 Americans with rare diseases, approximately two-thirds are children,” said
Peter L. Saltonstall, President and CEO of the National Organization for Rare Disorders (NORD).
“Many of these rare pediatric diseases are very serious and treatments are desperately needed. By
expanding priority review vouchers to include pediatric rare diseases, this legislation would
encourage the development of treatments for children with serious rare diseases.”
“Pennsylvania Bio thanks Senator Casey for his continued commitment to the life sciences industry
and the thousands of patients in the United States who suffer from rare diseases,” stated
Christopher P. Molineaux, President, Pennsylvania Bio. “With nearly 7,000 rare diseases, defined as
diseases affecting 200,000 or fewer Americans, few treatment options exist for these small patient
populations because it is often prohibitive for companies to enter the rare disease marketplace.
Pennsylvania Bio encourages members of the 112th Congress to follow Senator Casey’s lead and
take the necessary steps to support corporations who are conducting research into treatments for
these rare diseases, many of which affect children.”
Despite this significant unmet medical need, private companies seldom pursue new therapies for
tropical illnesses or rare diseases because it requires making an investment in products that will
likely not recoup the high costs associated with their research, development, marketing and
distribution. Developing products for children is particularly challenging because of the difficulties
associated with conducting clinical trials on this population.
Currently, pharmaceutical companies can receive a priority review voucher (PRV) if they develop
novel treatments for neglected tropical diseases, entitling the company to a priority six month review
of another new drug application that would otherwise be reviewed under the FDA’s standard ten
month review period. This shortened review time, which can lead to earlier market entry, is estimated
to be worth hundreds of millions of dollars.
The Creating Hope Act of 2011 will build on the PRV program to create a stronger incentive for
companies to invest in new treatments for rare diseases affecting children and neglected tropical
Robert P. Casey Jr. | United States Senator for Pennsylvania: Newsroom - ... http://casey.senate.gov/newsroom/press/release/?id=a8deb1ac-6ffd-424b...
2 of 3 7/15/2011 11:37 AM
APPENDIX C GlaxoSmithKline - Positions on Legislation - By MapLight - May 7, 2012 Page 18
diseases. This legislation will:
• Expand priority review vouchers to include treatments for pediatric rare diseases, so that
there is greater incentive to close the devastating treatment gap for kids.
• Close a loophole in current law to prevent companies from receiving a voucher for products
that they already market in other countries.
• Offer unlimited transferability of vouchers to create a more easily-traded asset.
• Provide greater certainty to sponsors by permitting them to seek a designation from FDA
before they submit their new drug application that the drug, if approved, will qualify for a voucher.
• Strengthen reporting and marketing requirements by requiring that the sponsor submit a
statement of good faith intent to market the eligible drug.
• Add Chagas disease, which is responsible for more deaths in Central and South America
than every other parasite-borne disease, to FDA’s list of neglected tropical diseases.
The following groups and businesses have endorsed the legislation: Aeras Global TB Vaccine
Foundation, Association of Pediatric Oncology Social Workers, American Society of Clinical
Oncology, American Society of Pediatric Hematology and Oncology, American Society for Tropical
Medicine and Hygiene (ASTMH), Bio Ventures for Global Health, Chai Lifeline, Children's Brain
Tumor Foundation, Children’s Hospital of Philadelphia, Children’s Hospital of Pittsburgh of UPMC,
CureSearch, GlaxoSmithKline, Genzyme, Kids v Cancer, Leukemia & Lymphoma Society, The
National Association of Children’s Hospitals, The National Children's Cancer Society, National
Organization for Rare Disorders, Novartis, Medicines for Malaria Venture (MMV), Merck, Metronomix,
Sarcoma Foundation of America, Pennsylvania BIO, Shire, CSL Behring, TB Alliance.
###
Robert P. Casey Jr. | United States Senator for Pennsylvania: Newsroom - ... http://casey.senate.gov/newsroom/press/release/?id=a8deb1ac-6ffd-424b...
3 of 3 7/15/2011 11:37 AM
APPENDIX D GlaxoSmithKline - Positions on Legislation - By MapLight - May 7, 2012 Page 19
For Immediate Release Contact: Bill Mashek March 8, 2011 202.354.8275
America Invents Act Boosts Innovation and Jobs, Strengthens Patent System
Coalition Appreciates Bipartisan Support in Senate and Looks Forward to House Action
Washington, D.C. – After the U.S. Senate’s overwhelming vote this evening to adopt S. 23, The America Invents Act, Gary Griswold of the Coalition for 21st Century Patent Reform released the following statement: “With the approval of S. 23, The America Invents Act, the U.S. Senate has moved the nation forward in promoting innovation, protecting inventions and enhancing the operations of the U.S. Patent and Trademark Office. The bipartisan leadership of Chairman Leahy, Senators Grassley, Hatch, Kyl, Klobuchar and others, as well as the efforts of the Administration, were instrumental in securing such a strong vote for helping America’s inventors. As amended, S. 23 answers the call of American innovators because this bill will give the USPTO the tools and funding it needs to process patents in a more effective and efficient way. Accordingly, this legislation will make our nation more competitive in the global marketplace and set in place rules that will benefit the next generation of inventors. It is clear that the 112th Congress wants to promote innovation and create jobs; adoption of S. 23 is a major step forward in achieving these goals. It is very encouraging that the members of the House and Senate have been in discussions on the issue and that the House Judiciary Committee is actively moving ahead with its consideration of patent reform. Our Coalition looks forward to continuing to work with members of the Senate and the House to produce fair and balanced patent reform legislation.”
-- 30 --
The Coalition has approximately 50 members from 18 diverse industry sectors and includes many of the nation’s leading manufacturers and researchers. The coalition’s steering committee includes 3M, Caterpillar, General Electric, Johnson & Johnson, Eli Lilly and Procter & Gamble. The Coalition has members in a variety of industry sectors including: Aerospace and Defense, Chemical, Computers, Diversified Financials, Diversified Technology, Energy, Food Production, Forest & Paper Products, Health Care, Household & Personal Products, Industrial Equipment, Medical Equipment & Devices, Network & Communications, Payroll Services, Pharmaceutical, Biotechnology, Semiconductors & Electronic Components, and Transportation Equipment. Visit http://www.patentsmatter.com for more information.
APPENDIX E GlaxoSmithKline - Positions on Legislation - By MapLight - May 7, 2012 Page 20
Email address:
For Immediate Release Contact: Bill MashekApril 2, 2009 202.354.8275 [email protected]
Coalition Supports Patent Reform LegislationAdopted in Senate Judiciary Committee
Bill Will Strengthen America's Patent System, Stimulate Invention andCreate Jobs
Washington, D.C. — The Chairman of the Coalition for 21st Century Patent Reform,Gary Griswold, released the following statement after the Senate JudiciaryCommittee adopted S. 515, The Patent Reform Act of 2009, by a 15-4 vote. As thebill moves to the Senate floor, the Coalition will continue to work in support of theeffort to improve the U.S. patent system.
"For more than six years, the Congress has worked on comprehensive patent reformlegislation. Today's strong vote by the Senate Judiciary Committee is an importantand meaningful step toward needed reform. The compromise package offered byChairman Leahy, Senator Specter, Senator Feinstein and other Senators had ourCoalition's strong support. As the patent reform bill proceeds through the legislativeprocess, we will continue to work with other Members of Congress to make furthertechnical changes which will facilitate the bill moving toward enactment.
Our Coalition appreciates and recognizes the focus and hard work by Senators andtheir staff over the past several weeks that led to the reporting of the bill by theCommittee. The compromise package, together with the other critical provisions ofthe bill, should improve the U.S. patent system.
With today's vote, the 111th Congress has set a course that will foster Americaninnovation and employment by ensuring the patent system is fair, balanced andpromotes research and innovation."
-- 30 --
The coalition has 50 members from 18 diverse industry sectors and includes many ofthe nation's leading manufacturers and researchers. The coalition's steeringcommittee includes 3M, Caterpillar, General Electric, Johnson & Johnson, Eli Lilly andProcter & Gamble. The coalition has members in a variety of industry sectorsincluding: Aerospace and Defense, Chemical, Computers, Diversified Financials,Diversified Technology, Energy, Food Production, Forest & Paper Products, HealthCare, Household & Personal Products, Industrial Equipment, Medical Equipment &Devices, Network & Communications, Payroll Services, Pharmaceutical,Biotechnology, Semiconductors & Electronic Components, and TransportationEquipment.
Download as PDF
September 16, 2011Leahy/Smith AmericaInvents Act PositionsInventors to “Win theFuture” (pdf)
September 8, 2011Senate Vote SendsLeahy/Smith AmericaInvents Act to White House(pdf)
August 14, 2011How to Encourage AmericanInnovation
June 23, 2011Coalition Praises HouseApproval of Leahy/SmithAmerica Invents Act (pdf)
June 21, 2011The Coalition for 21stCentury Patent Reformreaffirms its support formoving H.R. 1249. (pdf)
Home | About Us | Know the Issue | Press Room | Join Us | Member Login | Contact Us
© 2010 The Coalition for 21st Century Patent Reform
Patents Matter - The Coalition for 21st Century Patent Reform http://patentsmatter.com/press/20090402_support_statement.htm
1 of 1 5/2/2012 4:31 PM